Tirzepatide is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus treatment The most common side effects are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort The medication slows gastric emptying and reduces appetite, which may contribute to digestive symptoms Seek urgent medical attention for severe abdominal pain, persistent vomiting, signs of dehydration, or allergic reactions Report suspected side effects to the MHRA through the Yellow Card scheme Table of Contents Are Hiccups a Side Effect of Mounjaro
May your reconstitutions stay accurate, your timing stay consistent, and your results stay progressive.
Beavers KM, Walkup MP, Weaver AA, Lenchik L, Kritchevsky SB, Nicklas BJ, et al
Compare pricing transparently: see the Weight Management Protocols for MTM-first semaglutide and tirzepatide, or start with the Precision Peptide Genetic Test to understand your GLP-1 pathway before you subscribe
Jaspers AW, Cox JL, Krumholz HM
